Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105) 105
index medicus (71) 71
male (51) 51
female (49) 49
adult (46) 46
infectious diseases (45) 45
travel (42) 42
middle aged (40) 40
microbiology (38) 38
health aspects (36) 36
immunology (35) 35
animals (29) 29
travelers (29) 29
medicine, general & internal (28) 28
adolescent (26) 26
infection (26) 26
virology (26) 26
aged (24) 24
physics (23) 23
infections (22) 22
hepatitis (19) 19
beer (18) 18
biochemistry (18) 18
chemistry (18) 18
compositions thereof (18) 18
culture media (18) 18
enzymology (18) 18
human necessities (18) 18
hygiene (18) 18
medical or veterinary science (18) 18
metallurgy (18) 18
microorganisms or enzymes (18) 18
mutation or genetic engineering (18) 18
peptides (18) 18
preparations for medical, dental, or toilet purposes (18) 18
propagating, preserving or maintaining microorganisms (18) 18
spirits (18) 18
vinegar (18) 18
wine (18) 18
research (17) 17
risk factors (17) 17
vaccines (17) 17
dengue (16) 16
organic chemistry (16) 16
public, environmental & occupational health (16) 16
vaccination (16) 16
young adult (16) 16
epidemiology (15) 15
hepatitis c virus (15) 15
immunization (15) 15
cross infection (14) 14
nosocomial infections (14) 14
virus diseases (14) 14
aged, 80 and over (13) 13
australia (13) 13
hepatitis b virus (13) 13
hepatitis b virus - genetics (13) 13
investigating or analysing materials by determining theirchemical or physical properties (13) 13
measuring (13) 13
mice (13) 13
risk (13) 13
testing (13) 13
vaccine (13) 13
child (12) 12
compositions or test papers therefor (12) 12
condition-responsive control in microbiological orenzymological processes (12) 12
hepacivirus - immunology (12) 12
hepatitis b (12) 12
measuring or testing processes involving enzymes, nucleicacids or microorganisms (12) 12
processes of preparing such compositions (12) 12
allergy and immunology (11) 11
astrophysics (11) 11
cell line (11) 11
child, preschool (11) 11
countries (11) 11
fever (11) 11
viruses (11) 11
australia - epidemiology (10) 10
dengue - epidemiology (10) 10
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (10) 10
general tagging of cross-sectional technologies spanning over several sections of the ipc (10) 10
general tagging of new technological developments (10) 10
global health (10) 10
hepatitis c (10) 10
immune-responses (10) 10
medicine (10) 10
prevention (10) 10
processes using microorganisms (10) 10
retrospective studies (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
technical subjects covered by former uspc (10) 10
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (10) 10
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (10) 10
analysis (9) 9
dendritic cells (9) 9
gastroenterology & hepatology (9) 9
hepatocellular-carcinoma (9) 9
medicine, research & experimental (9) 9
sentinel surveillance (9) 9
biotechnology & applied microbiology (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The rationale for a preventative HCV Virus-Like Particle (VLP) Vaccine
by Torresi, Joseph
Frontiers in Microbiology, ISSN 1664-302X, 11/2017, Volume 8, p. 2163
HCV represents a global health problem with similar to 200 million individuals currently infected, worldwide. With the high cost of antiviral therapies, the... 
Virus like particles | Hepatitis C | Hepatitis C vaccines | Neutralizing antibody | HEPATITIS-C-VIRUS | neutralizing antibody | MICROBIOLOGY | INJECTING DRUG-USERS | B SURFACE-ANTIGEN | SUSTAINED VIROLOGICAL RESPONSE | T-CELL RESPONSES | ENVELOPE GLYCOPROTEIN 2 | BROADLY NEUTRALIZING ANTIBODIES | IMMUNE-RESPONSES | virus like particles | E2 GLYCOPROTEIN | HUMAN MONOCLONAL-ANTIBODIES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Editorial
by Torresi, Joseph
Journal of Travel Medicine, ISSN 1195-1982, 01/2016, Volume 23, Issue 1, pp. 1 - 1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Redefining priorities towards graded travel-related infectious disease research
by Torresi, Joseph and Steffen, Robert
Journal of Travel Medicine, ISSN 1195-1982, 11/2017, Volume 24, Issue 6
Abstract Our knowledge of the health problems and infections encountered by international travellers has evolved considerably in the past decades. The growth... 
GRADE | Malaria | Travel vaccines | Vaccinomics | Network studies | Travel medicine research | RETURNED TRAVELERS | INFECTIOUS DISEASES | network studies | HEPATITIS-A | RABIES POSTEXPOSURE PROPHYLAXIS | SENTINEL SURVEILLANCE DATA | GEOSENTINEL SURVEILLANCE | CLINICAL-FEATURES | malaria | TETRAVALENT DENGUE VACCINE | SYSTEMS BIOLOGY APPROACH | HUMAN GUT MICROBIOME | MEDICINE, GENERAL & INTERNAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | travel vaccines | vaccinomics | travel medicine research | ZIKA VIRUS | Travel-Related Illness | Disease Transmission, Infectious | Global Health | Health Priorities | Research Design | Humans | Medicine | Travel | Traveltime | Infectious diseases | Travellers | Health problems | Research | Epidemiology | Travel medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Illness in Travelers Visiting Friends and Relatives: A Review of the GeoSentinel Surveillance Network
by Karin Leder and Steven Tong and Leisa Weld and Kevin C. Kain and Annelies Wilder-Smith and Frank von Sonnenburg and Jim Black and Graham V. Brown and Joseph Torresi and GSS Network and GeoSentinel Surveillance Network
Clinical Infectious Diseases, ISSN 1058-4838, 11/2006, Volume 43, Issue 9, pp. 1185 - 1193
Travelers returning to their country of origin to visit friends and relatives (VFRs) have increased risk of travel-related health problems. We examined... 
Travel | Demography | Tuberculosis | Malaria | Travelers | Diarrhea | Infections | Preventive medicine | Travel medicine | Diseases | UNITED-STATES | INFECTIOUS DISEASES | COUNTRIES | INTERNATIONAL-TRAVEL | RISK | MICROBIOLOGY | IMMUNOLOGY | ATTITUDES | SEXUALLY-TRANSMITTED-DISEASES | INFECTIOUS-DISEASES | MALARIA | HEALTH KNOWLEDGE | HIV TRANSMISSION | Communicable Diseases - classification | Friends | Humans | Middle Aged | Child, Preschool | Infant | Male | Communicable Disease Control | Adolescent | Aged, 80 and over | Adult | Family | Female | Aged | Child | Emigration and Immigration | Evaluation | Demographic aspects | Research | Health aspects | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Editorial
by Torresi, Joseph
Journal of travel medicine, 01/2016, Volume 23, Issue 1
Travel Medicine | Periodicals as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Editorial
by Torresi, Joseph
Journal of travel medicine, 01/2016, Volume 23, Issue 1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
by Torresi, Joseph and Johnson, Doug and Wedemeyer, Heiner
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 54, Issue 6, pp. 1273 - 1285
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the worlds’ population causing significant morbidity and mortality.... 
Gastroenterology and Hepatology | Preventative vaccines | Therapeutic vaccines | Antivirals | Cellular immunity | Vaccines | Hepatitis C | Neutralising antibody | NEUTRALIZING ANTIBODIES | DENDRITIC CELLS | HYPERVARIABLE REGION 1 | GENETIC-VARIATION | T-CELL RESPONSES | PEGINTERFERON ALPHA-2B | IMMUNE-RESPONSES | IN-VIVO | NONSTRUCTURAL PROTEIN-3 | GASTROENTEROLOGY & HEPATOLOGY | PHASE-I | Antibodies, Viral - biosynthesis | Hepatitis C - therapy | Hepacivirus - immunology | Humans | Clinical Trials as Topic | Viral Hepatitis Vaccines - therapeutic use | Virus Internalization | Host-Pathogen Interactions - immunology | Epitopes - immunology | Hepatitis C - immunology | Models, Immunological | Animals | Antibodies, Neutralizing - biosynthesis | Viral Hepatitis Vaccines - isolation & purification | Hepatitis C - prevention & control | Immunity, Cellular | Virus diseases | Peptides | Dendritic cells | Cross infection | Nosocomial infections | Biological response modifiers | Hepatitis C virus | T cells | Health aspects | Recombinant proteins | Antigenic determinants
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations
by Hall, V and Johnson, D and Torresi, J
JOURNAL OF TRAVEL MEDICINE, ISSN 1195-1982, 03/2018, Volume 25, Issue 1
Background: Biologic therapy has revolutionized the management of refractory chronic autoimmune and auto-inflammatory disease, as well as several malignancies,... 
RHEUMATOID-ARTHRITIS | INFECTIOUS DISEASES | ANTI-TNF | INTERLEUKIN-1 RECEPTOR ANTAGONIST | JUVENILE IDIOPATHIC ARTHRITIS | B-CELL DEPLETION | MONOCLONAL-ANTIBODY | infection risk | Travel | PNEUMOCOCCAL VACCINE | MEDICINE, GENERAL & INTERNAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INFLAMMATORY-BOWEL-DISEASE | biologic agent | INFLUENZA VACCINATION | vaccine response | NECROSIS FACTOR THERAPY | Biological Factors - therapeutic use | Immunocompromised Host - immunology | Travel-Related Illness | Humans | Vaccination | Quality of Life | Risk | Communicable Disease Control - methods | Health care | Therapy | Infections | Vaccines | Immunity | Risks | Literature reviews | Biological effects | Immunology | Defence mechanisms | Remission | Yellow fever | Immune system | Vector-borne diseases | Immune response | Risk groups | Immunomodulation | Health risks | Agents | Disease control | Patients | Fever | Quality of life | Medicine | Immunosuppression | Risk management | Best practice
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis
by Gregor Ebert and Cody Allison and Simon Preston and James Cooney and Jesse G. Toe and Michael D. Stutz and Samar Ojaimi and Nikola Baschuk and Ueli Nachbur and Joseph Torresi and John Silke and C. Glenn Begley and Marc Pellegrini
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2015, Volume 112, Issue 18, pp. 5803 - 5808
We have shown that cellular inhibitor of apoptosis proteins (cIAPs) impair clearance of hepatitis B virus (HBV) infection by preventing TNF-mediated... 
Smac mimetic | Cellular inhibitor of apoptosis proteins | Hepatitis B virus | Birinapant | TNF | CANCER-CELLS | IMMUNITY | ACTIVATION | VIRUS-INFECTION | hepatitis B virus | MULTIDISCIPLINARY SCIENCES | PERSISTENT LCMV INFECTION | birinapant | RESPONSES | THERAPY | REACTIVATION | MOUSE MODEL | cellular inhibitor of apoptosis proteins | Hepatitis B - metabolism | Guanine - analogs & derivatives | Hepatocytes - metabolism | Hepatitis B Surface Antigens - blood | Hepatocytes - cytology | Guanine - pharmacology | Inhibitor of Apoptosis Proteins - antagonists & inhibitors | Indoles - pharmacology | Inhibitor of Apoptosis Proteins - metabolism | Disease Models, Animal | Antiviral Agents - pharmacology | Microscopy, Electron, Scanning | CD4-Positive T-Lymphocytes - cytology | Dipeptides - pharmacology | Liver - metabolism | Mice, Inbred C57BL | Immunophenotyping | Plasmids - metabolism | Mice, Inbred C3H | DNA, Viral - blood | Animals | Hepatitis B - drug therapy | Hepatocytes - virology | Mice | Prevention | Viral proteins | Host-virus relationships | Observations | Health aspects | Hepatitis B | Apoptosis | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cutaneous melioidosis: a review of the literature
by Fertitta, Laura and Monsel, Gentiane and Torresi, Joseph and Caumes, Eric
International Journal of Dermatology, ISSN 0011-9059, 02/2019, Volume 58, Issue 2, pp. 221 - 227
Background Melioidosis is mainly observed in South‐East Asia, where Burkholderia pseudomallei is endemic. Cutaneous melioidosis (CM) has rarely been described... 
PSEUDOMALLEI | DERMATOLOGY | Abscess - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Melioidosis - surgery | Skin Diseases, Bacterial - diagnosis | Meropenem - therapeutic use | Skin Diseases, Bacterial - surgery | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Melioidosis - drug therapy | Skin Diseases, Bacterial - complications | Melioidosis - complications | Melioidosis - diagnosis | Drug Therapy, Combination | Infectious Disease Incubation Period | Ceftazidime - therapeutic use | Therapy | Incubation | Clavulanic acid | Chronic infection | Infections | Cellulitis | Patients | Literature reviews | Melioidosis | Surgery | Abscesses | Amoxicillin | Cotrimoxazole | Skin | Meropenem | Diagnostic systems | Burkholderia | Localization | Ceftazidime
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus
by Gregor Ebert and Simon Preston and Cody Allison and James Cooney and Jesse G. Toe and Michael D. Stutz and Samar Ojaimi and Hamish W. Scott and Nikola Baschuk and Ueli Nachbur and Joseph Torresi and Ruth Chin and Danielle Colledge and Xin Li and Nadia Warner and Peter Revill and Scott Bowden and John Silke and C. Glenn Begley and Marc Pellegrini
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2015, Volume 112, Issue 18, pp. 5797 - 5802
Hepatitis B virus (HBV) infection can result in a spectrum of outcomes from immune-mediated control to disease progression, cirrhosis, and liver cancer. The... 
cIAP2 | cIAP1 | Cellular inhibitor of apoptosis proteins | Hepatitis B virus | TNF | hepatitis B virus | MULTIDISCIPLINARY SCIENCES | DISEASE | ALPHA | MICE | INFECTION | BLOCKADE | cellular inhibitor of apoptosis proteins | T-CELLS | Tumor Necrosis Factor-alpha - metabolism | Hepatitis B - metabolism | Baculoviral IAP Repeat-Containing 3 Protein | Hepatocytes - metabolism | Interferon-gamma - metabolism | Inhibitor of Apoptosis Proteins - metabolism | Disease Models, Animal | Liver Neoplasms - virology | Cytokines - metabolism | Signal Transduction | Liver - metabolism | Mice, Inbred C57BL | Ubiquitin-Protein Ligases - metabolism | Genotype | Immunophenotyping | CD8 Antigens - metabolism | Immunosuppression | Phenotype | Animals | Liver Neoplasms - metabolism | Hepatocytes - virology | Mice | DNA, Viral - genetics | CD4 Antigens - metabolism | Host-virus relationships | Viral proteins | Observations | Health aspects | Apoptosis | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Vitamin D Deficiency Is Associated with Tuberculosis and Latent Tuberculosis Infection in Immigrants from Sub-Saharan Africa
by Katherine B. Gibney and Lachlan MacGregor and Karin Leder and Joseph Torresi and Caroline Marshall and Peter R. Ebeling and Beverley-Ann Biggs
Clinical Infectious Diseases, ISSN 1058-4838, 2/2008, Volume 46, Issue 3, pp. 443 - 446
Among African immigrants in Melbourne, Victoria, Australia, we demonstrated lower geometric mean vitamin D levels in immigrants with latent tuberculosis... 
Vitamin D deficiency | Brief Reports | Infectious diseases | Tuberculosis | Mycobacterium tuberculosis | Vitamin D | Geometric mean | Pulmonary tuberculosis | Latent tuberculosis | Infections | Refugees | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | UNIT | LONDON | PULMONARY TUBERCULOSIS | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | REFUGEES | Tuberculosis - epidemiology | Humans | Middle Aged | Risk Factors | Male | Tuberculosis - microbiology | Vitamin D Deficiency - microbiology | Australia - epidemiology | Mycobacterium tuberculosis - isolation & purification | Vitamin D Deficiency - epidemiology | Adolescent | Adult | Africa South of the Sahara - ethnology | Female | Aged | Retrospective Studies | Emigrants and Immigrants | Tuberculosis - metabolism | Physiological aspects | Immigrants | Health aspects | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Dengue fever and international travel
by Ratnam, Irani and Leder, Karin and Black, Jim and Torresi, Joseph
Journal of Travel Medicine, ISSN 1195-1982, 11/2013, Volume 20, Issue 6, pp. 384 - 393
BackgroundDengue is a leading public health problem with an expanding global burden. Dengue virus is also a significant cause of illness in international... 
RETURNED TRAVELERS | INFECTIOUS DISEASES | VIRUS-INFECTION | RISK-FACTORS | RAPID TEST | CLINICAL-FEATURES | NS1 ELISA | NORTH QUEENSLAND | G AVIDITY TEST | MEDICINE, GENERAL & INTERNAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | VACCINE CANDIDATE | HEMORRHAGIC-FEVER | Travel | Communicable Diseases - ethnology | Disease Outbreaks - statistics & numerical data | Dengue - ethnology | Global Health | Humans | Immunoglobulins | Health aspects | Dengue | Public health | Vaccines | Dengue fever | Travel medicine | Morbidity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
by Torresi, Joseph and McCarthy, Karen and Feroldi, Emmanuel and Méric, Claude
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 50, pp. 7993 - 8000
Abstract Japanese encephalitis chimeric virus vaccine (JE-CV) was developed to replace licensed mouse brain-derived vaccine (MBD-JE), the production of which... 
Allergy and Immunology | Clinical trial, phase 3 | Attenuated vaccines | Japanese encephalitis vaccines | NONHUMAN-PRIMATES | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | WILD-TYPE | VIRUS-VACCINE | PROTECTION | CANDIDATE | CHIMERIVAX-JE | IMMUNOLOGY | IMMUNIZATION | RECOMBINANT | SA14-14-2 | Japanese Encephalitis Vaccines - administration & dosage | Double-Blind Method | Humans | Japanese Encephalitis Vaccines - immunology | Middle Aged | Male | Neutralization Tests | Japanese Encephalitis Vaccines - adverse effects | Antibodies, Viral - blood | Young Adult | Vaccines, Attenuated - immunology | Encephalitis, Japanese - prevention & control | Vaccines, Attenuated - administration & dosage | Adolescent | Aged, 80 and over | Adult | Female | Aged | Vaccines, Attenuated - adverse effects | Antibodies, Neutralizing - blood | Clinical trials | Product development | Vaccines | Health aspects | Vaccination | Japanese encephalitis | Studies | Encephalitis | Licenses | Military personnel | Drug dosages | Tropical diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights